Trifluoperazine hydrochloride
Trifluoperazine Hydrochloride is a generic prescription antipsychotic medication available as 1 mg film-coated oral tablets, manufactured by Sandoz Inc. It belongs to the phenothiazine class and is used to treat conditions like schizophrenia and severe anxiety. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Trifluoperazine Hydrochloride is a generic prescription antipsychotic medication available as 1 mg film-coated oral tablets, manufactured by Sandoz Inc. It belongs to the phenothiazine class and is used to treat conditions like schizophrenia and severe anxiety. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Trifluoperazine hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Trifluoperazine hydrochloride — ANDA 040209 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040209"
}
]
|
| identifier | ANDA040209 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-manufacturers",
"health-care",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Trifluoperazine hydrochloride |
